• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有SFTPC基因新生突变的婴儿的间质性肺疾病。

Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene.

作者信息

Brasch F, Griese M, Tredano M, Johnen G, Ochs M, Rieger C, Mulugeta S, Müller K M, Bahuau M, Beers M F

机构信息

Institute of Pathology, University Hospital Bergmannsheil, Bochum, Germany.

出版信息

Eur Respir J. 2004 Jul;24(1):30-9. doi: 10.1183/09031936.04.00000104.

DOI:10.1183/09031936.04.00000104
PMID:15293602
Abstract

Mutations in the surfactant protein C gene (SFTPC) were recently reported in patients with interstitial lung disease. In a 13-month-old infant with severe respiratory insufficiency, a lung biopsy elicited combined histological patterns of nonspecific interstitial pneumonia and pulmonary alveolar proteinosis. Immunohistochemical and biochemical analyses showed an intra-alveolar accumulation of surfactant protein (SP)-A, precursors of SP-B, mature SP-B, aberrantly processed proSP-C, as well as mono- and dimeric SP-C. Sequencing of genomic DNA detected a de novo heterozygous missense mutation of the SFTPC gene (g.1286T>C) resulting in a substitution of threonine for isoleucine (173T) in the C-terminal propeptide. At the ultrastructural level, abnormal transport vesicles were detected in type-II pneumocytes. Fusion proteins, consisting of enhanced green fluorescent protein and wild-type or mutant proSP-C, were used to evaluate protein trafficking in vitro. In contrast to wild-type proSP-C, mutant proSP-C was routed to early endosomes when transfected into A549 epithelial cells. In contrast to previously reported mutations, the 173T represents a new class of surfactant protein C gene mutations, which is marked by a distinct trafficking, processing, palmitoylation, and secretion of the mutant and wild-type surfactant protein C. This report heralds the emerging diversity of phenotypes associated with the expression of mutant surfactant C proteins.

摘要

最近有报道称,间质性肺疾病患者存在表面活性蛋白C基因(SFTPC)突变。在一名患有严重呼吸功能不全的13个月大婴儿中,肺活检显示出非特异性间质性肺炎和肺泡蛋白沉积症的联合组织学模式。免疫组织化学和生化分析显示,肺泡内积聚了表面活性蛋白(SP)-A、SP-B前体、成熟SP-B、异常加工的前SP-C以及单体和二聚体SP-C。基因组DNA测序检测到SFTPC基因发生了一个新生的杂合错义突变(g.1286T>C),导致C末端前肽中的异亮氨酸被苏氨酸取代(173T)。在超微结构水平上,在II型肺泡上皮细胞中检测到异常运输囊泡。由增强型绿色荧光蛋白和野生型或突变型前SP-C组成的融合蛋白被用于评估体外蛋白质转运。与野生型前SP-C不同,突变型前SP-C转染到A549上皮细胞后被转运至早期内体。与先前报道的突变不同,173T代表了一类新的表面活性蛋白C基因突变,其特征是突变型和野生型表面活性蛋白C在转运、加工、棕榈酰化和分泌方面存在明显差异。本报告预示着与突变型表面活性蛋白C表达相关的表型正在呈现出多样性。

相似文献

1
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene.一名患有SFTPC基因新生突变的婴儿的间质性肺疾病。
Eur Respir J. 2004 Jul;24(1):30-9. doi: 10.1183/09031936.04.00000104.
2
Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene.非特异性间质性肺炎、肺泡蛋白沉积症以及由表面活性蛋白C基因自发突变导致的异常前蛋白转运。
Pediatr Res. 2005 Jan;57(1):89-98. doi: 10.1203/01.PDR.0000147567.02473.5A. Epub 2004 Nov 19.
3
A novel surfactant protein C L55F mutation associated with interstitial lung disease alters subcellular localization of proSP-C in A549 cells.一种与间质性肺病相关的新型表面活性蛋白C L55F突变改变了A549细胞中前表面活性蛋白C的亚细胞定位。
Pediatr Res. 2016 Jan;79(1-1):27-33. doi: 10.1038/pr.2015.178. Epub 2015 Sep 16.
4
Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation.与表面活性蛋白C(SP-C)基因突变相关的可变表型:一例携带I73T突变的致命病例。
Eur Respir J. 2004 Dec;24(6):1072-3. doi: 10.1183/09031936.04.00092304.
5
A novel surfactant protein C mutation resulting in aberrant protein processing and altered subcellular localization causes infantile interstitial lung disease.一种导致异常蛋白质加工和亚细胞定位改变的新型表面活性蛋白C突变引起婴儿间质性肺病。
Pediatr Res. 2017 Jun;81(6):891-897. doi: 10.1038/pr.2017.29. Epub 2017 Feb 3.
6
Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease.伴有或不伴有肺纤维化疾病的婴儿肺泡蛋白沉积症中SFTPC的突变
Am J Med Genet A. 2004 Apr 1;126A(1):18-26. doi: 10.1002/ajmg.a.20670.
7
Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.与表面活性蛋白C突变相关的弥漫性肺疾病的临床和超微结构谱
Eur J Hum Genet. 2015 Aug;23(8):1033-41. doi: 10.1038/ejhg.2015.45. Epub 2015 Mar 18.
8
A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling.一种非聚集性表面活性蛋白 C 突变体被错误引导至早期内体,并破坏了磷脂的再循环。
Traffic. 2011 Sep;12(9):1196-210. doi: 10.1111/j.1600-0854.2011.01223.x. Epub 2011 Jun 28.
9
[Genetic basis in chronic interstitial familial pneumopathy. Familial study of SFTPC].[慢性间质性家族性肺病的遗传基础。SFTPC的家族研究]
Pediatr Med Chir. 2005 May-Aug;27(3-4):103-7.
10
SFTPC mutations cause SP-C degradation and aggregate formation without increasing ER stress.SFTPC 突变导致 SP-C 降解和聚集体形成,而不会增加内质网应激。
Eur J Clin Invest. 2013 Aug;43(8):791-800. doi: 10.1111/eci.12107. Epub 2013 May 24.

引用本文的文献

1
Endogenous gene editing of alveolar organoids reveals that expression of pathogenic variant SFTPC-I73T disrupts endosomal function, epithelial polarity and wound healing.肺泡类器官的内源性基因编辑表明,致病性变体SFTPC-I73T的表达会破坏内体功能、上皮极性和伤口愈合。
bioRxiv. 2025 Jul 22:2025.07.22.665497. doi: 10.1101/2025.07.22.665497.
2
REGULATORY T CELLS PROTECT AGAINST ABERRANT REMODELING IN A MOUSE MODEL OF PULMONARY FIBROSIS.调节性T细胞在肺纤维化小鼠模型中可防止异常重塑。
bioRxiv. 2025 Jul 5:2025.07.02.662777. doi: 10.1101/2025.07.02.662777.
3
Evaluating the Use of iPSC-Derived Models in Understanding the Pathogenesis of Childhood Interstitial Lung Disease.
评估诱导多能干细胞衍生模型在理解儿童间质性肺疾病发病机制中的应用。
Pediatr Pulmonol. 2025 May;60(5):e71143. doi: 10.1002/ppul.71143.
4
Targeting USP11 counteracts -associated interstitial lung disease in hiPSCs-derived alveolar organoids and in vivo models.靶向USP11可对抗人诱导多能干细胞衍生的肺泡类器官和体内模型中的特发性肺间质疾病。
Theranostics. 2025 Mar 19;15(10):4526-4549. doi: 10.7150/thno.105994. eCollection 2025.
5
A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease.一种新型的源自人类胎儿肺的肺泡类器官模型揭示了与间质性肺病相关的表面活性蛋白C成熟机制。
EMBO J. 2025 Feb;44(3):639-664. doi: 10.1038/s44318-024-00328-6. Epub 2025 Jan 15.
6
Common Mutations in the Surfactant Protein-C Gene in Iranian Patients with Diffuse Parenchymal Lung Disease.伊朗弥漫性实质性肺疾病患者表面活性物质蛋白C基因的常见突变
Tanaffos. 2024 Jan;23(1):65-72.
7
Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice.野生型II型肺泡上皮细胞在表面活性蛋白C缺陷小鼠中的植入。
Res Sq. 2024 Sep 13:rs.3.rs-4673915. doi: 10.21203/rs.3.rs-4673915/v1.
8
SGCAST: symmetric graph convolutional auto-encoder for scalable and accurate study of spatial transcriptomics.SGCAST:用于可扩展和准确研究空间转录组学的对称图卷积自动编码器。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad490.
9
A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease.一种新型的源自人类胎儿肺的肺泡类器官模型揭示了与间质性肺病相关的表面活性蛋白C成熟机制。
bioRxiv. 2023 Sep 4:2023.08.30.555522. doi: 10.1101/2023.08.30.555522.
10
Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell.基因治疗在表面活性物质功能障碍性疾病中的应用:以肺泡Ⅱ型上皮细胞为靶点。
Hum Gene Ther. 2022 Oct;33(19-20):1011-1022. doi: 10.1089/hum.2022.130.